MIT SCM Symposium 2024

Recent global events, particularly the COVID-19 outbreak, highlighted vulnerabilities in supply chains and the need for resilience in maintaining essential services, emphasizing the requirement for a robust Business Continuity Management (BCM) Plan. The sponsor (A leading pharmaceutical company with a global presence) currently has a revenue-first approach to risk management. Through this project, we aim to expand the sponsor’s current approach to include financial factors, inventory capabilities at each warehouse, customer profiles, and current business continuity management practices. This project's scope covers all warehouses within the sponsor’s downstream network, focusing on last-mile delivery from the sponsor’s warehouses to its patients. The deliverables include a framework through which the sponsor can understand the risk concentration for each of their warehouses depending on business needs. By providing a more holistic view of risks and incorporating lessons learned from the pandemic, the project aims to enhance the sponsor's ability to adapt to evolving challenges in the pharmaceutical supply chain, ensuring continuity and stability in the face of unforeseen disruptions.